We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
AbbVie Inc | NYSE:ABBV | NYSE | Common Stock |
Price Change | % Change | Share Price | |
---|---|---|---|
2.98 | 1.85% | 163.79 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
164.25 | 160.74 | 161.85 | 5,850,104 | 01:00:00 |
Date | Time | Source | Headline |
---|---|---|---|
08/1/2024 | 14:16 | DJN | AbbVie to Move Lutikizumab Into Phase 3 in Hidradenitis Suppurativa |
04/1/2024 | 14:29 | DJN | AbbVie, Umoja Biopharma Set CAR-T Cell Therapies Collaboration |
03/1/2024 | 23:17 | DJN | Abbvie Stock Edges Lower After CVS Says It Will Drop Humira From Some.. |
03/1/2024 | 22:59 | DJN | CVS Health To Cover Humira Biosimilars April 1 |
13/12/2023 | 16:29 | DJN | AbbVie Currently Up 11 Consecutive Days, on Pace for Longest Winning Streak.. |
12/12/2023 | 16:24 | DJN | AbbVie Currently Up 10 Consecutive Days, on Pace for Longest Winning Streak.. |
08/12/2023 | 15:28 | DJN | AbbVie Currently Up Eight Consecutive Days, on Track for Longest Winning.. |
07/12/2023 | 16:48 | DJN | AbbVie Currently Up Seven Consecutive Days, on Track for Longest Winning.. |
07/12/2023 | 15:27 | DJN | Trending: AbbVie to Buy Cerevel for $45 a Share |
06/12/2023 | 22:10 | DJN | AbbVie to Buy Cerevel Therapeutics for $8.7 Billion -- Update |
1 Year AbbVie Chart |
Intraday AbbVie Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions